Structures by: Loubidi M.
Total: 7
3,4,6-Trimethyl-1-phenyl-5-(thiophen-3-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine
C19H17N3S
IUCrData (2018) 3, 11 x181593
a=7.6672(3)Å b=9.9098(4)Å c=11.4101(4)Å
α=82.5480(10)° β=78.176(2)° γ=76.607(2)°
Ethyl 4-(3,4,6-trimethyl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-5-yl)benzoate
C24H23N3O2
IUCrData (2018) 3, 10 x181449
a=8.6962(12)Å b=8.7349(12)Å c=14.559(2)Å
α=106.468(2)° β=92.949(2)° γ=111.771(2)°
C18H17N5O
C18H17N5O
RSC Advances (2019) 9, 50 29051
a=10.7895(4)Å b=14.8634(7)Å c=10.0794(5)Å
α=90° β=92.246(4)° γ=90°
<i>N</i>-(<i>tert</i>-butyl)-2-(phenylethynyl)imidazo[1,2-<i>a</i>]pyridin-3-\ amine
C19H19N3
Acta Crystallographica Section E (2019) 75, 10 1564-1567
a=9.3492(2)Å b=16.3716(3)Å c=10.8030(2)Å
α=90° β=90° γ=90°
12-{[4-(4-Bromophenyl)piperazin-1-yl]methyl}-9α-hydroxy-4,8-dimethyl-3,14-dioxatricyclo[9.3.0.0^2,4^]tetradec-7-en-13-one
C25H33BrN2O4
Acta Crystallographica Section E (2014) 70, 4 o497-o498
a=9.6790(4)Å b=7.0710(3)Å c=17.3117(7)Å
α=90.00° β=94.872(2)° γ=90.00°
9α-Hydroxy-12-{[4-(4-hydroxyphenyl)piperazin-1-yl]methyl}-4,8-dimethyl-3,14-dioxatricyclo[9.3.0.0^2,4^]tetradec-7-en-13-one
C25H34N2O5
Acta Crystallographica Section E (2014) 70, 5 o530-o531
a=29.880(5)Å b=6.841(5)Å c=11.999(5)Å
α=90.000° β=102.307(5)° γ=90.000°
(1<i>S</i>,2<i>R</i>,3<i>S</i>,6<i>S</i>,7<i>R</i>)-3,7,11,11-Tetramethyl-6,7-epoxybicyclo[5.4.0]undecane-2-ol
C15H26O2
Acta Crystallographica Section E (2014) 70, 5 o595
a=5.9617(10)Å b=12.068(2)Å c=9.5909(15)Å
α=90.00° β=95.789(8)° γ=90.00°